Pflug Koory’s Bristol-Myers Squibb BMY Stock Holding History

Pflug Koory’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Sell	18,688 -200	-1%	-$11.5K	0.43%	59
2026 Q1	$1.15M	Hold	18,888	–	–	0.52%	54
2025 Q4	$1.02M	Sell	18,888 -100	-0.5%	-$4.81K	0.48%	57
2025 Q3	$856K	Sell	18,988 -134	-0.7%	-$6.26K	0.41%	63
2025 Q2	$885K	Hold	19,122	–	–	0.45%	61
2025 Q1	$1.17M	Sell	19,122 -289	-1%	-$16.8K	0.65%	48
2024 Q4	$1.1M	Sell	19,411 -75	-0.4%	-$4.19K	0.56%	52
2024 Q3	$1.01M	Buy	+19,486	New	+$914K	0.5%	59
2024 Q1	$1.08M	Buy	19,888 +424	+2%	+$21.6K	0.53%	60
2023 Q4	$999K	Sell	19,464 -305	-2%	-$16K	0.53%	57
2023 Q3	$1.15M	Hold	19,769	–	–	0.66%	45
2023 Q2	$1.26M	Sell	19,769 -140	-0.7%	-$9.39K	0.64%	45
2023 Q1	$1.38M	Sell	19,909 -140	-0.7%	-$9.87K	0.75%	40
2022 Q4	$1.44M	Sell	20,049 -50	-0.2%	-$3.77K	0.8%	36
2022 Q3	$1.43M	Buy	20,099 +27	+0.1%	+$1.96K	0.87%	32
2022 Q2	$1.55M	Sell	20,072 -3,020	-13%	-$230K	0.89%	33
2022 Q1	$1.69M	Sell	23,092 -448	-2%	-$30.1K	0.85%	30
2021 Q4	$1.47M	Buy	23,540 +4	+0%	+$235	0.74%	37
2021 Q3	$1.39M	Sell	23,536 -858	-4%	-$56.5K	0.76%	39
2021 Q2	$1.63M	Buy	24,394 +800	+3%	+$52.2K	0.85%	30
2021 Q1	$1.49M	Buy	23,594 +860	+4%	+$53.5K	0.82%	35
2020 Q4	$1.41M	Buy	22,734 +300	+1%	+$18.4K	0.83%	35
2020 Q3	$1.35M	Sell	22,434 -200	-0.9%	-$12K	0.91%	30
2020 Q2	$1.33M	Hold	22,634	–	–	0.99%	28
2020 Q1	$1.26M	Buy	22,634 +50	+0.2%	+$3.06K	1.12%	23
2019 Q4	$1.45M	Sell	22,584 -266	-1%	-$15.2K	1.03%	25
2019 Q3	$1.16M	Buy	22,850 +585	+3%	+$27.5K	0.88%	36
2019 Q2	$1.01M	Buy	22,265 +595	+3%	+$27.7K	0.77%	43
2019 Q1	$1.03M	Buy	21,670 +4,080	+23%	+$203K	0.81%	40
2018 Q4	$914K	Buy	17,590 +7,120	+68%	+$383K	0.78%	42
2018 Q3	$650K	Hold	10,470	–	–	0.53%	58
2018 Q2	$579K	Buy	10,470 +50	+0.5%	+$2.7K	0.46%	73
2018 Q1	$659K	Hold	10,420	–	–	0.54%	61
2017 Q4	$639K	Hold	10,420	–	–	0.51%	67
2017 Q3	$664K	Sell	10,420 -150	-1%	-$8.76K	0.54%	63
2017 Q2	$589K	Hold	10,570	–	–	0.5%	68
2017 Q1	$575K	Buy	10,570 +70	+0.7%	+$3.84K	0.5%	64
2016 Q4	$613	Buy	+10,500	New	+$574K	0.53%	60

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Pflug Koory's BMY Position: Q2 2026 in Review

Pflug Koory reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, selling an estimated $11.5K and leaving 18,688 shares worth $1.08M. The position accounts for 0.43% of the portfolio, ranked #59.

Pflug Koory first reported a position in BMY in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.69M in Q1 2022. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Pflug Koory held 18,688 shares of Bristol-Myers Squibb worth $1.08M as of Q2 2026.
Pflug Koory sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
Bristol-Myers Squibb made up 0.43% of Pflug Koory's portfolio in Q2 2026, its #59 holding.
Pflug Koory first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 38 quarters since.
Pflug Koory's Bristol-Myers Squibb position peaked at $1.69M in Q1 2022.
889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.